ALPS Advisors’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-37,287
Closed -$156K 1074
2025
Q3
$156K Sell
37,287
-4,315
-10% -$27.6K ﹤0.01% 1012
2025
Q2
$386K Sell
41,602
-14,726
-26% -$128K ﹤0.01% 793
2025
Q1
$549K Sell
56,328
-4,589
-8% -$56.8K ﹤0.01% 579
2024
Q4
$738K Buy
60,917
+8,616
+16% +$105K ﹤0.01% 544
2024
Q3
$573K Buy
52,301
+4,410
+9% +$44.8K ﹤0.01% 592
2024
Q2
$431K Buy
47,891
+4,597
+11% +$32K ﹤0.01% 613
2024
Q1
$354K Buy
43,294
+3,520
+9% +$28.9K ﹤0.01% 812
2023
Q4
$335K Sell
39,774
-3,776
-9% -$43.8K ﹤0.01% 795
2023
Q3
$745K Buy
43,550
+1,083
+3% +$21.3K 0.01% 539
2023
Q2
$986K Buy
42,467
+5,140
+14% +$100K 0.01% 497
2023
Q1
$659K Buy
37,327
+3,612
+11% +$85.9K 0.01% 540
2022
Q4
$917K Buy
33,715
+6,763
+25% +$141K 0.01% 498
2022
Q3
$465K Sell
26,952
-2,162
-7% -$41.2K ﹤0.01% 604
2022
Q2
$509K Sell
29,114
-19,408
-40% -$319K ﹤0.01% 598
2022
Q1
$824K Sell
48,522
-5,747
-11% -$108K 0.01% 331
2021
Q4
$1.47M Sell
54,269
-3,053
-5% -$91.3K 0.02% 322
2021
Q3
$1.7M Sell
57,322
-4,065
-7% -$132K 0.02% 334
2021
Q2
$2.36M Sell
61,387
-21,761
-26% -$744K 0.02% 277
2021
Q1
$2.54M Buy
83,148
+1,853
+2% +$69.4K 0.02% 240
2020
Q4
$3.1M Buy
81,295
+29,916
+58% +$1.25M 0.03% 211
2020
Q3
$1.18M Buy
51,379
+1,393
+3% +$31.7K 0.02% 329
2020
Q2
$1.24M Sell
49,986
-14,901
-23% -$264K 0.02% 279
2020
Q1
$647K Sell
64,887
-7,559
-10% -$113K 0.01% 394
2019
Q4
$1.04M Buy
+72,446
New +$1.04M 0.01% 342

Other funds holding REPL

ALPS Advisors's REPL Position: Q4 2025 in Review

ALPS Advisors sold out of Replimune Group (REPL) in Q4 2025, closing a stake of 37,287 shares — an estimated $156K sold.

ALPS Advisors first reported a position in REPL in Q4 2019 and held it in 24 quarters. The position peaked at $3.1M in Q4 2020. 164 funds tracked by Wall St. Rank hold REPL as of Q4 2025.

  • ALPS Advisors reported no remaining Replimune Group position as of Q4 2025 after selling out during the quarter.
  • ALPS Advisors sold 37,287 Replimune Group shares in Q4 2025, an estimated $156K.
  • ALPS Advisors first reported a position in Replimune Group in Q4 2019 and held it in 24 quarters.
  • ALPS Advisors's Replimune Group position peaked at $3.1M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Replimune Group as of Q4 2025.

Based on ALPS Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.